Synergistic Optimization of Bacillus subtilis for Efficiently Producing Menaquinone-7 (MK-7) by Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Metabolic Engineering
Fermentation · 12.03.2025 · 11 (3) · 137
DOI: 10.3390/fermentation11030137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fermentation, online erschienen am 12.03.2025. Verfasst von Meng Li und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Green Bio-fabrication Program of China, Class I project of independent innovation of agricultural science and technology in Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Menaquinone-7 (MK-7) plays a crucial role in preventing fractures and certain cardiovascular diseases and is one of the essential vitamins in the human body. In this study, a strain of Bacillus subtilis that produces MK-7 was isolated from commercially available natto fermentation agents, with an MK-7 titer of 75 mg/L. It was named L-5. Firstly, by employing Atmospheric and Room Temperature Plasma (ARTP) mutagenesis technology and protoplast fusion techniques, mutants resistant to 1-hydroxy-2-naphthoic acid (HNA) and diphenylamine (DPA) were obtained, with the titer of MK-7 reaching 196 mg/L. It was named R-8. Based on whole-genome sequencing technology, four mutants involved in the MK-7 synthesis pathway of strain L-5 were identified: 2-succinyl-5-enol-pyruvate-6-hydroxy-3-cyclohexen-1-carboxylic acid, MenD (S249L); (1,4)-dihydroxy-2-naphthalic acid-heptaisoprenyltransferase, MenA (S196L); 1-deoxy-D-xylose-5-phosphate synthetase, Dxs (N60D, Q185H); and hydroxy acid reductive isomerase, Dxr (Q351K). The overexpression of these mutants led to increases in MK-7 production of 19 mg/L, 20 mg/L, 17 mg/L, and 16 mg/L, respectively, compared to the unmutated genes. These mutations have been shown to be effective. To further enhance the production of MK-7, the mutants menD (S249L), menA (S196L), Dxs (N60D, Q185H), and Dxr (Q351K) were co-expressed. The final titer of MK-7 reached 239 mg/L. This study provides theoretical support for the future genetic modification of key enzymes in the MK-7 biosynthetic pathway.
Förderung
- Green Bio-fabrication Program of China
- Class I project of independent innovation of agricultural science and technology in Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Li, J., Li, Y., Zhang, X., & Xu, J. (2025). Synergistic Optimization of Bacillus subtilis for Efficiently Producing Menaquinone-7 (MK-7) by Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Metabolic Engineering. Fermentation, 11(3), 137. https://doi.org/10.3390/fermentation11030137
Vancouver
Li M, Li J, Li Y, Zhang X, Xu J. Synergistic Optimization of Bacillus subtilis for Efficiently Producing Menaquinone-7 (MK-7) by Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Metabolic Engineering. Fermentation. 2025;11(3):137. doi:10.3390/fermentation11030137
BibTeX
@article{Li2025,
author = {Li, Meng and Li, Jiachang and Li, Yufei and Zhang, Xian and Xu, Jianzhong},
title = {Synergistic Optimization of Bacillus subtilis for Efficiently Producing Menaquinone-7 (MK-7) by Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Metabolic Engineering},
journal = {Fermentation},
year = {2025},
volume = {11},
number = {3},
pages = {137},
doi = {10.3390/fermentation11030137}
}
EUVIMED